The Bulgarian Drug Agency officially joined the PIC/S
post-template-default,single,single-post,postid-1888,single-format-standard,bridge-core-3.1.8,cookies-not-set,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-30.5,qode-theme-bridge,wpb-js-composer js-comp-ver-7.6,vc_responsive

The Bulgarian Drug Agency officially joined the PIC/S

The Bulgarian Drug Agency (BDA) officially joined the PIC/S – Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme as its 55th Participating Authority, effective from July 1, 2023.

PIC/S is a non-binding co-operative arrangement between Regulatory Authorities in the field of Good Manufacturing Practice (GMP) of medicinal products for human or veterinary use. It is open to any Authority having a comparable GMP inspection system. PIC/S comprises more than 50 Participating Authorities coming from all over the world (Europe, Africa, America, Asia, and Australia).

PIC/S aims at harmonizing inspection procedures worldwide by developing common standards in the field of GMP and by providing training opportunities to inspectors. It also aims at facilitating co-operation and networking between competent authorities, regional and international organizations, thus increasing mutual confidence.

The country’s membership in PIC/S will bring benefits primarily to the Bulgarian pharmaceutical industry, but also to the international recognition of BDA, not only within the EU, but also on a global scale.